Becky Jones Sues After 11 Years of Chemotherapy for Brain Inflammation Misdiagnosed as Cancer
Updated
Updated · bbc.co.uk · Sep 13
Becky Jones Sues After 11 Years of Chemotherapy for Brain Inflammation Misdiagnosed as Cancer
3 articles · Updated · bbc.co.uk · Sep 13
Summary
33-year-old Becky Jones says she spent 11 years on chemotherapy after being told at 21 she had a terminal grade-four brain tumour and only months to live.
A 2025 independent review for her lawyers found she never had brain cancer but tumefactive demyelination—brain inflammation usually treated with strong steroids—despite scans that showed no visible tumour.
Royal College of Physicians preliminary findings said patients were routinely kept on temozolomide for 10 to 15 years with little or no evidence of benefit; 15 of 20 reviewed cases were judged unsatisfactory overall.
UHCW said affected patients have been reviewed, new oversight of temozolomide prescribing is in place, and further action will follow once the full RCP report is published.
With reviews now targeting deceased patients, how many more lives were tragically ruined by this hospital's catastrophic decade-long chemotherapy blunder?
What really happened behind closed doors when a doctor convinced a healthy young woman to treat an invisible brain tumor for a decade?
How did an entire hospital staff silently watch a healthy woman endure eleven years of toxic chemotherapy without ever speaking up?
Decade-Long Chemotherapy Without Cause: Inside the UHCW NHS Trust Scandal, Patient Harm, and the Push for National Cancer Care Reform
Overview
The UHCW scandal exposed how a lack of multidisciplinary oversight, unchecked clinical autonomy, and failures across pathology, pharmacy, and leadership led to over 40 patients receiving years of unnecessary chemotherapy. Misdiagnoses—often confusing treatable inflammatory brain conditions with aggressive cancer—went unchallenged as pharmacy teams, senior clinicians, and hospital leaders failed to question prolonged treatments. This resulted in devastating physical and psychological harm, including cases of severe organ damage and secondary cancers. The Royal College of Physicians’ review found widespread substandard care, prompting legal action and national reforms to strengthen clinical governance, diagnostic safety, and patient protections across the UK.